Green synthesis of iron oxide nanoparticles demonstrates improved blood glucose levels in diabetic rats, suggesting new therapeutic strategies.
Introduction: This study uses the green synthesis method to explore the synthesis and evaluation of iron oxide nanoparticles (IONPs) derived from the extract of Nishamalaki for their antidiabetic potential. Method: The synthesis of IONPs from Nishamalaki (NA-IONPs) was confirmed by Fourier transform infrared (FTIR) spectroscopy, which identified key peaks associated with metal-oxide bonds, water-molecule vibrations, and polyphenolic compounds in the extract. Additionally, Scanning Electron Microscopy (SEM), X-ray diffraction (XRD), and Vibrating Sample Magnetometer (VSM) were performed to evaluate the morphological structure, crystallinity, and magnetic property of synthesized IONPs. The antidiabetic potential of synthesized NA-IONPs was also evaluated on diabetic rats. Results: Notably, the 547.68 cm-1 peak corresponds to the Fe-O bond, and the 1631.48 cm-1 peak indicates OH-bonding in polyphenolic compounds. Additionally, SEM analysis revealed that the NA-IONPs were spherical with diameters less than 100 nm, and displayed superparamagnetic properties (40 emu/g as measured by VSM). Furthermore, NA-IONPs have shown a significant reduction in blood glucose levels, dropping from 291.5±0.56 to 113±1.44 over 15 days compared with the diabetic control group. Discussion: The in vivo antidiabetic studies demonstrated that the synthesized NA-IONPs significantly lowered blood glucose levels and improved metabolic function in diabetic animal models. Furthermore, histopathological analysis revealed that NA-IONPs can help regenerate β-cell and islet structure, indicating their potential for antidiabetic applications. Conclusion: This research bridges the gap between traditional Ayurvedic medicine and modern nanotechnology, highlighting the potential of NA-IONPs as an innovative approach for diabetes management. These findings contribute valuable insights into the development of advanced therapeutic strategies for diabetes control.
No takes yet. Share an insight, caveat, or question.
Parmanik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: